Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Pekin, IL – FDA Inspections
Inspection records and compliance data for Linde Inc. in Pekin, Illinois. 2 FDA inspections on record, last inspected April 17, 2014. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Pekin, Illinois, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected June 12, 2013. Last inspected April 17, 2014.
Most cited issue areas
- Correct labels during finishing operations1 inspection
- Prepared for each batch, include complete information1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 17, 2014 | VAI | Human Drugs · Drug Quality Assurance | 874876 |
| June 12, 2013 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 835586 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
3002486140
Address
1225 S Front St, Pekin, Illinois 61554, United States
Country
United States
ID: a1fb3d42-c6a4-4d1a-b272-5f4cc47934fd